Skip to content
DivinhealLogo
Guide

Preimplantation Genetic Testing (PGT) Success Rate in Chennai

Hospital background

Plan My Journey

Tell us your condition and budget - our AI matches the right destination, hospital and doctor and visa pathway

Cost calculator

I know my treatment - show me cost from 3 hospitals

5K+ International Patients Treated

40+ Source Countries Served

500+ Accredited Partner Hospitals

98% Patient Satisfaction

80% Average Savings vs USA

10K+ Doctors

NABH, JCI Accredited Hospitals

Free Treatment Plan

Free Consultation with Doctor

5+ Destinations Covered

Dr Indu Priya

Written by DivinHeal Editorial Contributor, Rahul Kumar, Embryologist | Medically Reviewed by Dr Indu Priya, Gynecologist(MD) Published on: September 2, 2026

How success is measured for Preimplantation Genetic Testing (PGT)

Clinics measure outcome quality through live birth rates per euploid embryo transfer rather than initial positive pregnancy tests.

Testing checks embryo chromosomes before implantation. This helps specialists select healthy embryos for transfer.

MeasureWhat it counts
Live birth rate per transferHow often a transferred embryo results in a delivered baby.
Implantation rateHow often a transferred embryo attaches to the uterine lining.
Clinical pregnancy rateHow often ultrasound confirms a gestational sac with a heartbeat.
Miscarriage rateHow often a confirmed pregnancy ends before full term.

Live Birth Rate per Euploid Embryo Transfer

The live birth rate per euploid embryo transfer counts actual baby deliveries from chromosomally normal embryos.

A chromosomally normal embryo is called euploid. Transferring a euploid embryo provides the clearest outcome measure.

Euploid embryo selection lowers the risk of transfer failure. Doctors verify chromosome counts before frozen transfer.

Implantation Rates vs Overall Pregnancy Rates

Implantation rates measure uterine attachment, while overall pregnancy rates include early chemical marker detections.

In reproductive endocrinology and assisted reproduction, clinical pregnancy tracking confirms embryo heartbeats. These metrics describe women undergoing assisted reproduction with blastocyst biopsy.

Tracking implantation provides early feedback on uterine readiness. This helps fertility teams refine hormonal support protocols.

Reduction in Miscarriage Risk Post-Screening

Embryo genetic screening reduces miscarriage risk by excluding embryos with major chromosomal errors before transfer.

Chromosomal errors cause most early pregnancy losses. Screening prevents transferring embryos that cannot develop normally.

Miscarriage rates drop when chromosomally abnormal embryos are excluded. Patients experience higher pregnancy stability as a result.

Live birth per transfer offers the most accurate outcome tracking for testing in Chennai.

Success rate by country (location rate: 65.0%)

Published outcome figures vary globally based on patient age groups, diagnostic criteria, and national registry standards.

Registry reports gather patient data across multiple clinic networks over several calendar years.

Chennai, India: Benchmark 65.0% PGT Success Rate

Chennai fertility centres report outcomes to national registries using standardised transfer metrics.

Understanding the Preimplantation Genetic Testing (PGT) Success Rate in Chennai helps international families set realistic expectations. Local clinics follow guidelines from the Indian Council of Medical Research in Chennai, Tamil Nadu, India.

Indian registries collect data across accredited urban fertility centres. Specialists evaluate patient health factors alongside lab metrics.

Global Comparison: PGT Outcomes in USA, Europe, and Asia

Comparing figures across countries requires understanding differences in patient selection and transfer protocols.

Registries in different regions use varied reporting frameworks. A patient comparing international data should ask targeted questions.

Different regions record outcomes using varied baseline definitions. Understanding these nuances helps when comparing international clinic reports.

  • What exact outcome metric does the figure measure?
  • Which age brackets are included in the dataset?
  • Over what timeframe were these patient cases collected?
  • Does the figure include all initiated cycles or transfers only?

Evaluating global reports requires comparing identical patient categories and clinical reporting methods.

What affects your outcome

Embryo development, maternal health, and laboratory precision determine individual treatment results.

A specialist evaluates these factors during initial clinical consultations.

  • Maternal age and eggs retrieved per cycle
  • Embryology laboratory biopsy skills and equipment
  • Uterine receptivity and endometrial lining thickness
  • Type of genetic screening protocol required

Maternal Age and Oocyte Quality

Maternal age directly influences egg quality and the proportion of euploid embryos produced.

Older eggs have a higher risk of chromosomal copying errors. Testing helps identify the normal embryos among those retrieved.

Oocyte quality affects blastocyst formation rates in culture. Higher egg quality yields a greater number of testable blastocysts.

Embryology Lab Infrastructure and Biopsy Expertise

Advanced laboratory infrastructure protects delicate trophectoderm cells during embryo biopsy procedures.

Experienced embryologists remove few cells safely. Precise handling keeps blastocysts healthy for vitrification.

High-grade laser equipment enables safe trophectoderm biopsy. Laboratory environmental controls protect delicate embryos during processing.

Type of Testing Required (PGT-A, PGT-M, PGT-SR)

The required testing protocol depends on whether patients check general chromosome counts or single-gene conditions.

A detailed Embryo Genetic Testing in IVF 2026: PGT-A, PGD & Preimplantation Genetic Testing in India guide explains specific screening methods.

Specific gene probes require individual laboratory customization. Structural rearrangement testing demands specialized chromosomal mapping.

Laboratory biopsy precision and maternal egg health remain primary outcome drivers.

Who this treatment helps most

Embryo genetic testing benefits couples facing recurrent pregnancy loss, single-gene disorders, or repeated implantation failure.

Testing clarifies embryo viability before starting transfer cycles.

Couples with Advanced Maternal Age or Recurrent Pregnancy Loss

Patients with repeated miscarriages benefit by avoiding transfers of chromosomally abnormal embryos.

Screening identifies healthy embryos before transfer. This reduces physical strain from failed cycles.

Advanced maternal age increases the proportion of aneuploid embryos. Screening avoids unnecessary transfers that would not succeed.

Carriers of Monogenic Single-Gene Genetic Disorders

Carriers of single-gene conditions use targeted testing to prevent passing hereditary illnesses to offspring.

Targeted probes identify specific gene defects in embryos. Only unaffected embryos move forward for frozen transfer.

Single-gene defect screening protects future generations from inherited illnesses. Families gain clarity regarding embryo genetic health.

Patients with Multiple Unsuccessful IVF Cycles

Couples with repeated cycle failures use testing to uncover underlying embryonic chromosomal issues.

Selecting genetically normal embryos helps resolve unexplained transfer failures. Read our Euploid Embryo Guide: Why It Matters More Than You Think for insights.

Repeated failure often stems from silent chromosomal abnormalities. Identifying normal embryos helps overcome persistent implantation failure.

Genetic screening provides essential clarity for complex reproductive histories.

Safety, accreditation and where you'll be treated

Accredited laboratories enforce strict clinical protocols to protect embryo safety during biopsy and freeze cycles.

Strict safety standards ensure maximum protection for developing blastocysts.

Safety Protocols for Blastocyst Biopsy

Biopsies take cells exclusively from the outer trophectoderm layer, leaving inner fetus-forming cells untouched.

This safety protocol prevents harm to future fetal development. Skilled embryologists perform biopsies at day five.

Trophectoderm biopsy preserves the inner cell mass completely. Published evidence confirms this technique maintains embryo development potential.

Top IVF Clinics and Advanced Genomic Labs in Chennai

Leading medical centres maintain cleanroom facilities for genetic testing.

Patients can review Best Preimplantation Genetic Testing (PGT) Hospitals in Chennai to evaluate facility standards.

Chennai facilities utilize cleanrooms with advanced air filtration systems. Sterile lab environments protect embryos during biopsy.

NABH & CAP Certified Genetic Pathology Facilities

Accreditation from recognized bodies ensures high standards in genetic pathology testing.

National Accreditation Board for Hospitals & Healthcare Providers certification confirms quality systems. College of American Pathologists standards guide advanced diagnostics.

Certified facilities undergo regular third-party clinical quality audits. Pathologists follow strict laboratory processing guidelines.

Certified labs maintain rigid biopsy safety standards to safeguard embryo health.

What recovery looks like

Physical recovery after embryo biopsy involves resting while frozen embryos await genetic diagnostic results.

Embryo Cryopreservation & Vitrification Recovery

Vitrification safely freezes embryos while laboratory technicians conduct genetic screening.

Physical and Emotional Preparation for Frozen Embryo Transfer

Hormone therapy prepares the uterine lining for frozen transfer after results arrive.

Patients prepare over several weeks. Doctors verify endometrial readiness before scheduling transfer.

Physical recovery after retrieval allows time for uterine preparation before frozen transfer.

Cost alongside success

Financial costs depend on the number of embryos tested and specific laboratory panels required.

PGT Testing Cost Breakdown in Chennai vs Global Averages

Testing expenses cover biopsy procedures, genetic analysis probes, and frozen storage fees.

To compare options, review Preimplantation Genetic Testing (PGT) cost in Chennai details.

Evaluating Return on Investment for IVF + PGT Cycles

Screening reduces total cycles needed by avoiding transfers of non-viable embryos.

Financial planning should consider testing fees alongside frozen embryo transfer cycles.

How DivinHeal supports your outcome

DivinHeal connects international patients with verified fertility specialists and accredited pathology labs.

Matching You with Top Medical Specialists in Chennai

Our team helps you find experienced doctors suited to your specific reproductive needs.

Explore Best Preimplantation Genetic Testing (PGT) Doctors in Chennai for personalized care options. You can also review general pgt procedure information.

End-to-End Medical Tourism and Travel Coordination

DivinHeal handles medical travel logistics so families focus entirely on treatment.

  1. The specialist reviews complete medical and genetic history records.
  2. The clinical team evaluates ovarian reserve and previous cycle outcomes.
  3. The laboratory designs customized genetic testing panels for embryos.
  4. The embryologist monitors embryo growth to the blastocyst stage safely.
  5. The medical team develops a customized frozen transfer protocol.

DivinHeal simplifies international travel while connecting you with leading fertility experts.

Hospitals

NABH & JCI Accredited Hospitals in India,Turkey, Thailand & UAE.

View All
Doctors

Meet Our Medical Specialists

View All

How DivinHeal Helps

We simplify your medical journey by providing comprehensive support and access to world-class healthcare.

Expert Specialist Matching

Connecting you with the world's top-rated medical experts.

FAQ

Everything you
need to know today

Browse through these common inquiries to better understand our patient-focused medical platform.

Preimplantation refers to the stage of development in assisted reproduction before an embryo attaches to the uterine lining, allowing genetic screening to occur prior to pregnancy.

Yes, when performed by experienced embryologists using trophectoderm biopsy at the blastocyst stage (Day 5/6), PGT is safe and does not harm embryo development.

Transferring a chromosomally normal (euploid) embryo yields a high success rate, averaging around 60% to 65% live birth rate per transfer.

The benchmark PGT success rate in Chennai is 65.0%, backed by world-class embryology laboratories and advanced next-generation sequencing (NGS) technologies.

PGT-A (formerly PGS) screens embryos for chromosomal abnormalities (aneuploidy), whereas PGD (now PGT-M or PGT-SR) tests for specific inherited genetic diseases or structural rearrangements.

PGT-A is recommended for women over 35, couples with recurrent miscarriages, individuals with repeated IVF failure, or those facing severe male factor infertility.

Genetic sequencing of biopsy samples typically takes 2 to 3 weeks, after which frozen embryo transfer (FET) can be scheduled.

While PGT significantly reduces miscarriage risks and improves implantation rates, overall success also depends on uterine receptivity and general maternal health.

Still have more questions?

Book a call with our friendly team to learn how DivineHeal simplifies your healthcare journey.